Miller & Martin Leads Negotiations for Former Shareholders of Stability Biologics LLC (f/k/a Stability Inc.) to Acquire the Business from MiMedx Group, Inc.
August 22, 2017
Miller & Martin represented the Stockholder Representative, Brian Martin, in his negotiations for the former owners of Stability Biologics to acquire the business from MiMedx. Stability Biologics provides a full line of human allograft available for distribution in the surgical fields of spine, orthopedics and wound care. Miller & Martin represented the owners in their prior sale of Stability Biologics to MiMedx in 2016. MiMedx decided to divest Stability Biologics, and the former owners agreed to repurchase the business. Miller & Martin represented Mr. Martin to negotiate this transaction on behalf of the former owners and reorganize the company. Representing the Stockholder Representative, Brian Martin, were attorneys Joe DeLisle, Tim Silvis, Jonathan Edwards, Billy Eiselstein, Jimmy Daniel and Jim Tramonte.
To read more, please click here.